Ligand Pharmaceuticals Incorporated (LGND) — Analyst estimates
Consensus analyst estimates for Ligand Pharmaceuticals Incorporated — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 92.56M | 2.87 | 2 |
| 2027 | 96.26M | 3.18 | 2 |
| 2028 | 434.13M | 12.88 | 4 |
| 2029 | 510.93M | 13.81 | 2 |
| 2030 | 506.41M | 16.68 | 2 |
Consensus analyst estimates by fiscal year.